saw103

Scott A. Waldman, MD, PhD

Contact Dr. Waldman

132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107

(215) 955-6086
(215) 955-5681 fax

Most Recent Peer-reviewed Publications

  1. GUCY2C signaling opposes the acute radiation-induced GI syndrome
  2. ST-producing E. Coli oppose carcinogen-induced colorectal tumorigenesis in mice
  3. Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics
  4. Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention
  5. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
  6. Prime-boost immunization eliminates metastatic colorectal cancer by producing high-Avidity effector CD8+T cells
  7. Clinical Pharmacology & Therapeutics: Past, Present, and Future
  8. Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
  9. EXECUTIVE INTERVIEW - Viral gene: Protein-targeting cancer vaccine could boost survival rates
  10. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis
  11. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope
  12. A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients
  13. Guanylyl cyclase C signaling axis and colon cancer prevention
  14. Guanylyl cyclase C hormone axis at the intersection of obesity and colorectal cancer
  15. Targeting guanylate cyclase C in colorectal cancer: Where are we now?
  16. GUCY2C ligand replacement to prevent colorectal cancer
  17. Big data transforms discoveryutilization therapeutics continuum
  18. Obesity-induced colorectal cancer is driven by caloric silencing of the guanylin-GUCY2C paracrine signaling axis
  19. Bioinnovation Enterprise: An Engine Driving Breakthrough Therapies
  20. Intestinal enteroids model guanylate cyclase C-dependent secretion induced by heat-stable enterotoxins